Table 2.
Clinical characteristics of the study population
Groups | Number of samples | Gestational age at amniocentesis weeks; median (IQR) |
IL-6 concentration ng/mL; median (IQR) |
Gestational age at delivery weeks; median (IQR) |
|
---|---|---|---|---|---|
Absence of intra-amniotic infection/inflammation | 15-20 weeks | 6 | 17.7 (16.4-18.8) |
0.3 (0.1-0.8) |
38.4 (38.4-39.3) |
20-30 weeks | 8 | 23.2 (21.6-27.2) |
0.5 (0.2-0.9) |
28.6 (24.5-35.6) |
|
30-36 weeks | 9 | 32.3 (31.4-33.3) |
0.3 (0.2-0.4) |
33.9 (32.3-36) |
|
37-40 weeks | 34 | 39 (38.9-39.3) |
0.3 (0.3-0.7) |
39 (38.9-39.3) |
|
Intra-amniotic infection/inflammation (18-40 weeks) |
9 | 38.1 (22.3-39.6) |
70.6 (6.4-118.7) |
38.1 (22.7-39.6) |
IQR, interquartile range